₹634.85
▼ -0.95 -0.15%
17 Jul 2026
NSE Listed
Nephrocare Health Serv Limited (NEPHROPLUS)
Volume: 57,631Avg Vol 1W: 1,36,244.8Avg Vol 1M: 1,85,705.6552W Range:₹446₹769.75
Key Ratios
Checked 6h agoMarket Cap₹6,394 Cr
Current Price₹634.85
Previous Close₹635.8
High / Low (52w)₹769.75 / ₹446
Volume57,631
Avg Vol (1W)1,36,244.8
Avg Vol (1M)1,85,705.65
Stock P/E0
Book Value₹3,288.65
Dividend Yield—
ROE12%
ROA—
Revenue (TTM)₹770 Cr
Revenue Growth—
Profit Margin—
Total Debt₹96 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹380.15
P/B0
Debt / Equity0.53
50 DMA₹663.95
200 DMA₹575.72
Day change-0.15%
Price Chart
₹634.85▲ 34.72% · 1Y
2025-12-172026-07-16
20-day avg volume: 1.9L shares
Pros
- Company is almost debt-free.
Cons
- Revenue fell 11% YoY.
Quarterly Results
| Metric | Dec 2024 | Mar 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | ₹197 Cr | ₹219 Cr | ₹246 Cr | ₹260 Cr | ₹266 Cr |
| EBITDA | ₹31 Cr | ₹36 Cr | ₹44 Cr | ₹42 Cr | ₹39 Cr |
| Net Profit | ₹20 Cr | ₹25 Cr | ₹-9 Cr | ₹32 Cr | ₹30 Cr |
| EPS | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | ₹290 Cr | ₹327 Cr | ₹443 Cr | ₹575 Cr | ₹770 Cr |
| EBITDA | ₹8 Cr | ₹-17 Cr | ₹8 Cr | ₹53 Cr | ₹108 Cr |
| Net Profit | ₹1 Cr | ₹-21 Cr | ₹-12 Cr | ₹35 Cr | ₹67 Cr |
| EPS | 1.73 | -130.96 | -67.95 | 4.4 | 8.01 |
Balance Sheet
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Total Assets | ₹428 Cr | ₹571 Cr | ₹666 Cr | ₹806 Cr | ₹996 Cr |
| Total Liabilities | ₹169 Cr | ₹175 Cr | ₹278 Cr | ₹392 Cr | ₹412 Cr |
| Equity | ₹259 Cr | ₹396 Cr | ₹389 Cr | ₹414 Cr | ₹584 Cr |
| Total Debt | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹18 Cr | ₹19 Cr | ₹7 Cr | ₹80 Cr | ₹136 Cr |
| Investing | ₹-61 Cr | ₹-129 Cr | ₹-78 Cr | ₹-51 Cr | ₹-125 Cr |
| Financing | ₹36 Cr | ₹121 Cr | ₹60 Cr | ₹27 Cr | ₹54 Cr |
| Free Cash Flow | ₹18 Cr | ₹19 Cr | ₹7 Cr | ₹80 Cr | ₹136 Cr |
Shareholding
Promoter 63.85% Institutions 18.58% Public 17.56%
Efficiency & Working Capital
ROCE13.2%
Interest Coverage5.2
Dividend Payout—
Debtor Days129 d
Inventory Days13 d
Payable Days55 d
Cash Conversion Cycle87 d
Working Capital Days142 d
Shareholding Details
As of 2026-03-31
Promoter63.9%
FII9.9%
DII8.6%
Institutions18.6%
Public17.6%
Promoter Pledge0%
No. of Shareholders43,409
Shareholding Pattern
Quarterly — figures in %. Latest 4 quarters.
| Period | Jul 2025 | Jul 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Promoters | 79.1% | 79.1% | 63.9% | 63.9% |
| FIIs | 0% | 0% | 9.3% | 9.9% |
| DIIs | 20.9% | 0% | 8.1% | 8.6% |
| Public | 0% | 20.9% | 18.7% | 17.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% |
| No. of Shareholders | 65 | 65 | 67,416 | 43,409 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Edoras Investment Holdings Pte Ltd | Shareholding of Promoter and Promoter Group | 28.3% | 2.84 Cr |
| Vikram Vuppala | Shareholding of Promoter and Promoter Group | 9.8% | 98,24,227 |
| Bessemer Venture Partners Trust | Shareholding of Promoter and Promoter Group | 8.7% | 86,85,150 |
| Investcorp India Investments Holding Limited | Public Shareholding | 6.3% | 63,08,976 |
| Healthcare Parent Limited | Shareholding of Promoter and Promoter Group | 5.8% | 58,24,260 |
| Polar Capital Funds Plc - Healthcare Opportunities | Public Shareholding | 5.8% | 57,80,962 |
| Investcorp Private Equity Fund Ii | Shareholding of Promoter and Promoter Group | 5.3% | 53,33,510 |
| International Finance Corporation | Public Shareholding | 3.1% | 30,89,662 |
| Quadria Capital India Fund Iii | Shareholding of Promoter and Promoter Group | 1.9% | 18,82,080 |
| Viraaj Family Trust (trustee Ms. Manju Vuppala ) | Shareholding of Promoter and Promoter Group | 1.9% | 18,57,150 |
| The Prudential Assurance Company Limited | Public Shareholding | 1.8% | 18,40,364 |
| Manvi Family Trust (trustee Mr. Vikram Vuppala) | Shareholding of Promoter and Promoter Group | 1.8% | 17,72,265 |
| 360 One Special Opportunities Fund - Series 9 | Public Shareholding | 1.4% | 14,33,467 |
| Sbi Healthcare Opportunities Fund | Public Shareholding | 1.2% | 11,92,334 |
| Axis Max Life Insurance Limited | Public Shareholding | 1.1% | 10,56,997 |
| Investcorp India Alternatives Fund - Investcorp Gr | Shareholding of Promoter and Promoter Group | 0.5% | 4,74,630 |
| Pankaja Gatuku | Shareholding of Promoter and Promoter Group | 0% | 22,665 |
| Healthcare Private Equity Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Quadria Capital Fund Iii Holdings Pte. Ltd | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Anunta Technology Management Services Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Applied Energy Technologies Private Limited (formerly Known As Applied Solar Technologies (india)) | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bessemer India Capital Holdings Ii Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Intergrow Brands Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Paris De Salon Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Starlet Projects Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Vikram Vuppala | 0 | 0% | 2026-03-31 |
| Pullaiah Vuppala | 0 | 0% | 2026-03-31 |
| Susheela Vuppala | 0 | 0% | 2026-03-31 |
| Manju Kandagatla | 0 | 0% | 2026-03-31 |
| Viraaj Vuppala | 0 | 0% | 2026-03-31 |
| Manvi Vuppala | 0 | 0% | 2026-03-31 |
| Vijay Kumar Kandagatla | 0 | 0% | 2026-03-31 |
| Kavitha Devi Kandagatla | 0 | 0% | 2026-03-31 |
| Santosh Kumar | 0 | 0% | 2026-03-31 |
| Swetha Chunchu | 0 | 0% | 2026-03-31 |
| Shailaja Chintakindi | 0 | 0% | 2026-03-31 |
| Quadria Capital India Fund Iii | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Vikram Vuppala | Chairman & Managing Director | 2025 |
| Vishal Vijay Gupta | Non Executive Director / Nominee | 2025 |
| Gaurav Sharma | Non Executive Director / Nominee | 2025 |
| SUNIL KUMAR THAKUR | Non Executive Director / Nominee | 2025 |
| Om Prakash Manchanda | Independent Director | 2025 |
| HEMANT SULTANIA | Independent Director | 2025 |
| Annette Bent Ingrid Kumlien | Independent Director | 2025 |
| Ajay Bakslii | Independent Director | 2025 |
| Kishore Kathri | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 24 | 2 | 2 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Market19/12/2025 · 2,14,331
Company Information
🌐 www.nephroplus.com ↗
📍 5th Flr D Block iLabs Centre, Plot 18 Software Units Sy.#.64, Hyderabad, Telangana, 500081
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search